$68,359,693

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechexpiredONGOING · MOD OF 2015 CONTRACT

WORK BEGAN2015-09-15·LATEST ACTION2026-05-12·SOURCEUSASPENDING·SOURCE IDCONT_AWD_HHSO100201500029C_7505_-NONE-_-NONE-

Award description

IGF::OT::IGF

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: medium

In plain English

Latest obligation on a Pfizer vaccine or pandemic-preparedness contract that began in 2015 under HHS/ASPR.

Sub-sectors

vaccine-developmentpandemic-preparednessongoing-contract-modification

Why this matters

Reflects sustained federal investment in pharmaceutical surge capacity and vaccine readiness infrastructure spanning over a decade.

Supply-chain signal

Indicates continued reliance on Pfizer as a strategic supplier for federal pandemic response and vaccine manufacturing capability.

U.S.–China competition angle

Demonstrates U.S. commitment to domestic biopharmaceutical capacity as a counterweight to supply-chain vulnerabilities exposed during COVID-19.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-03. Cost: $0.002879.

Period of performance

Start

2015-09-15

End

2025-09-30

Status

expired287 days ago

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_HHSO100201500029C_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.